MDWD

MediWound Ltd. MDWD

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,597 of 2,925

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$16.96M

Quarter to Dec 31

Net income

$-23.88M

Quarter to Dec 31

Free cash flow

$-21.63M

Quarter to Dec 31

Operating margin

-149.0%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$85.54M total
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

MDWD key financials by period

Reported revenue, net income and operating margin by fiscal year, from MediWound Ltd.'s annual filings on SEC EDGAR.

MediWound Ltd. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$17.0M$-23.9M-149.0%
FY 2024$20.2M$-30.2M-95.9%
FY 2023$18.7M$-6.7M-81.8%
FY 2022$26.5M$-19.6M-31.5%
FY 2021$23.8M$-13.6M-47.2%
FY 2020$21.8M$-9.2M-40.6%
Source: MDWD filings on SEC EDGAR →

MDWD insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MediWound Ltd. (MDWD): stock profile, AI score and financials

MediWound Ltd. (MDWD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MDWD at 26.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,597 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), MediWound Ltd. reports quarterly revenue of $17.0M, net income of $-23.9M, an operating margin of -149.0%. Top institutional holders of MDWD by reported 13-F value include INVESTOR AB, Yelin Lapidot Management Ltd., Rosalind Advisors, based on the most recent SEC filings. MDWD trades on the Nasdaq exchange and files with the SEC under CIK 1593984. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDWD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MediWound Ltd. directly from SEC EDGAR.

SEC EDGAR: CIK 1593984 →